Functional diversity of the CD8+ T-cell response to Epstein-Barr virus (EBV): Implications for the pathogenesis of EBV-associated lymphoproliferative disorders

Blood

Volumn 91, Issue 10, 1998, Pages 3875-3883

  Nazaruk, Rachel A ^b   Rochford, Rosemary ^b   Hobbs, Monte V ^b   Cannon, Martin J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LATENT VIRUS INFECTION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS CARCINOGENESIS; VIRUS REACTIVATION;

EID: 0032525297     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3875.3875_3875_3883     Document Type: Article

References (43)

1. Qu L, Rowe DT: Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J Virol 66:3715, 1992
2. Tierney RJ, Steven N, Young LS, Rickinson AB: Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374, 1994
3. Khanna R, Burrows SR, Moss DJ: Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev 59:387, 1995
4. Rickinson AB, Lee SP, Steven NM: Cytotoxic T lymphocyte responses to Epstein-Barr virus. Curr Opinion Immunol 8:492, 1996
5. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG: Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685, 1995
6. Crawford DH, Sweny P, Edwards JM, Janossy G, Hoffbrand AV: Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet 1:10, 1981
7. Gaston JSH, Rickinson AB, Epstein MA: Epstein-Barr virus-specific T-cell memory in renal-allograft recipients under long-term immunosuppression. Lancet 1:923, 1982
8. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL: Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 39:461, 1985
9. Randhawa PS, Yousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J: The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heartlung transplant patients. Am J Clin Pathol 92:177, 1989
10. Wilkinson AH, Smith JL, Hunsicker LG, Tobacman J, Kapelanski DP, Johnson M, Wright FH, Behrendt DM, Corry RJ: Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 47:293, 1989
11. Nalesnik M: Posttransplantation lymphoproliferative disorders: Current perspectives. Semin Thoracic Cardiovasc Surg 8:139, 1996
12. Rooney CM, Smith CA, Ng CYC, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE: Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345:9, 1995
13. Heslop HE, Ng CYC, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM: Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 2:551, 1996
14. Boyle TJ, Berend KR, DiMaio JM, Coles RE, Via DF, Lyerly HK: Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma. Surgery 114:218, 1993
15. + cytotoxic T cells against Epstein-Barr virus-immortalized B cell tumors in SCID mice. Transplantation 58:629, 1994
16. Lacerda JF, Ladanyi M, Louie DC, Fernandez JM, Papadopoulos EB, O'Reilly RJ: Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B.-17 scid/scid mice. J Exp Med 183:1215, 1996
17. Hill AB, Lee SP, Haurum JS, Murray N, Yao Q-Y, Rowe M, Signoret N, Rickinson AB, McMichael AJ: Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV) nuclear antigens fail to lyse the EBV-transformed B lymphoblastoid cell lines against which they were raised. J Exp Med 181:2221, 1995
18. Carter L, Dutton RW: Type 1 and type 2: A fundamental dichotomy for all T-cell subsets. Curr Opinion Immunol 8:336, 1996
19. Banchereau J, de Paoli P, Valle A, Garcia E, Roussel F: Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70, 1991
20. Openshaw PJM, Murphy EE, Hosken NA, Maino V, Davis K, Murphy K, O'Garra A: Heterogeneity of intracellular cytokine synthesis at the single cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 182:1357, 1995
21. + T cells from young and old mice. J Immunol 150:3602, 1993
22. De Vries JE: Molecular and biological characteristics of interleukin-13. Chem Immunol 63:204, 1996
23. Rochford R, Cannon MJ, Sabbe RE, Picchio G, Noonan DJ, Mosier DE, Hobbs MV: Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. Viral Immunol 10:183, 1997
24. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Bloom BR: Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279, 1991
25. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 180:489, 1994
26. + T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with Hyper-IgE. J Exp Med 181:423, 1995
27. + T cell clones can provide B cell help. J Immunol 154:3118, 1995
28. Cocks BG, de Waal Malefyt R, Galizzi J-P, de Vries JE, Aversa G: IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 5:657, 1993
29. Van der Pouw Kraan TCTM, Boeije LCM, Troon JTM, Rutschmann SK, Wijdenes J, Aarden LA: Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A. J Immunol 156:1818, 1996
30. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547, 1993
31. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin-10 inhibits human lymphocyte IFN-γ production by suppressing natural killer cell stimulatory factor/interleukin-12 synthesis in accessory cells. J Exp Med 178:1041, 1993
32. Trinchieri G: Cytokines acting on or secreted by macrophages during intracellular infection (IL-1O, IL-12. IFN-γ). Curr Op Immunol 9:17, 1997
33. + suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms. J Immunol 150:2121, 1993
34. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosman TR: Interleukin 10. Annu Rev Immunol 11:165, 1993
35. Gerosa F, Paganin C, Peritt D, Paiola F, Scupoli MT, AsteAmezaga M, Frank I, Trinchieri G: Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10. J Exp Med 183:2559, 1996
36. + T cell clones. J Immunol 141:849, 1988
37. Miyashita EM, Yang B, Lam, KMC, Crawford DH, Thorley-Lawson DA: A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593, 1995
38. Thorley-Lawson DA, Miyashita EM, Khan G: Epstein-Barr virus and the B cell: That's all it takes. Trends Microbiol 4:204, 1996
39. Veronese ML, Veronesi A, D'Andrea E, Del Mistro A, Indraccolo S, Mazza MR, Mion M, Zamarchi R, Menin C, Panozzo M, Amadori A, Chieco-Bianchi L: Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation. J Exp Med 176:1763, 1992
40. Coles RE, Boyle TJ, DiMaio JM, Berend KR, Via DF, Lyerly HK: T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice. Ann Surg Oncol 1:405, 1994
41. Rousset F, Garcia E, DeFrance T, Peronne C, Vezzio N, Hsu D, Kastelstein R, Moore KW, Banchereau J: Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890, 1992
42. Beatty PR, Krams SM, Martinez OM: Involvement of IL-IO in the autonomous growth of EBV-transformed cell lines. J Immunol 158:4045, 1997
43. Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA: Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 71:4882, 1997